Sirtratumab Vedotin Biosimilar - Research Grade

Sirtratumab vedotin is an ADC consisting of a SLITRK6-directed antibody and Monomethyl auristatin E (MMAE) used for the study of bladder cancer.

MMAE

CHO Cells

Human

SLITRK6

Functional Assays

1mg/mL

>90% by SDS-PAGE

Room Temp

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

IgG1

25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)

Reconstitute with sterile, distilled water to a final concentration of 1 mg/ml. Gently shake to solubilize completely. Do not vortex.